Health Benefits, Costs, and Cost-Effectiveness of Jail-Based Hepatitis C Elimination Strategies
In this cost-effectiveness analysis using a network simulation model, jail-based HCV elimination interventions, particularly those providing treatment during detention, reduced prevalent and incident HCV cases and HCV-related deaths among people who inject drugs both within and beyond jails. These interventions are a cost-effective strategy for public health decision-makers to consider.
Authors
- Nathan W. Furukawa (ORCID: https://orcid.org/0000-0002-4268-0556)
- Eman Addish
- Indrani Alhad Wagh
- Sandy R. Varghese
- Yijie Chen
- Marissa B Reitsma (ORCID: https://orcid.org/0000-0001-7276-4876)
- Joshua A. Salomon (ORCID: https://orcid.org/0000-0003-3929-5515)
- Amanda Honeycutt (ORCID: https://orcid.org/0000-0003-0166-1399)
- Danica Kuncio (ORCID: https://orcid.org/0000-0002-0777-5074)
- Lora Magaldi
- Lin Zhu
- Eliza R Ennis
- Benjamin P. Linas
Institutions
- Boston University (US)
- Boston Medical Center (US)
- Centers for Disease Control and Prevention (US)
- University of Miami (US)
- Clinical Orthopaedics and Related Research (US)
- National Center for Injury Prevention and Control (US)
- National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention (US)
- Philadelphia Department of Public Health (US)
- Philadelphia Fight (US)
- Stanford University (US)
Publication Details
- Journal
- JAMA Internal Medicine
- Published
- 2026-03-23
- DOI
- https://doi.org/10.1001/jamainternmed.2026.0190
- Primary Topic
- HIV, Drug Use, Sexual Risk
- Type
- article
- Field-Weighted Citation Impact
- 0.00